Table 1.
Reference | Number of Treated Glioblastomas | Photosensitiser | Light | Median Survival Time (Months) | ||||
---|---|---|---|---|---|---|---|---|
Trade Name | Agent | Dose | Localisation | Wavelength (nm) | Energy Density (J/cm2) | |||
Perria et al. (1980) [25] | Not defined | Photofrin® | Hematoporphyrin derivative (HpD) | 5 mg/kg | Cell membrane; mitochondria | 628 | 720–2400 | 6.9 |
Povovic et al. (1995) [26] | Newly diagnosed, 38 Recurrent, 40 | Photofrin® | Hematoporphyrin derivative (HpD) | 2–2.5 mg/kg | Cell membrane; mitochondria | 628 | 70–260 | Newly diagnosed, 24 Recurrent, 9 |
Rosenthal et al. (2003) [27] | Newly diagnosed, 7 Recurrent, 9 | BOPP | Boronated porphyrin | 0.25–8 mg/kg | Various, including mitochondria | 630 | 25–100 | Newly diagnosed, 7 Recurrent, 11 |
Stylli et al. (2005) [28] | Newly diagnosed, 31 Recurrent, 55 | Photofrin® | Hematoporphyrin derivative (HpD) | 5 mg/kg | Cell membrane; mitochondria | 628 | 70–240 | 14.3 |
Muller and Wilson, (2006) [29] | Newly diagnosed, 12 Recurrent, 37 | Photofrin® | Hematoporphyrin derivative (HpD) | 2 mg/kg | Cell membrane; mitochondria | 630 | Mean, 58 Maximum, 150 | 7.6 |
Kostron et al. (2006) [30] | Recurrent, 26 | Foscan® | mTHPC metatetrahydroxyphenylchlorin |
0.15 mg/kg | Golgi apparatus, endoplasmic reticulum, and mitochondria | 630 | 20 | Recurrent, 8.5 |
Stepp H. et al. (2007) [31] | Newly diagnosed, 20 | Levulan | 5-ALA | 20 mg/kg | mitochondria | 633 | 200 mW/cm2 | Newly diagnosed, 15.2 |
Beck T.J. et al., (2007) [32] | Recurrent GBM, 10 | Levulan | 5-ALA | 20 mg/kg | mitochondria | 633 | Total 4320–11,520 J (200 mW/cm) | 15 |
Eljamel (2008) [33] | Newly diagnosed, 13 | Photofrin® | Hematoporphyrin derivative (HpD) 5-ALA |
2 mg/kg | Cell membrane; mitochondria | 630 | 100 × 5 sessions | Newly diagnosed, Mean survival 52.8 weeks |
Kaneko et al., (2008) [34] | Total, 35 | Photofrin® | Hematoporphyrin derivative (HpD) | 2 mg/m2 | Cell membrane; mitochondria | 630 | 180 | Total, 20.5 |
Akimoto et al. (2012) [35] | Newly diagnosed, 4 Recurrent, 6 | Laserphyrin® | Talaporfin sodium | 40 mg/m2 | - | 664 | 27 | Newly diagnosed, 31 Reccurent, 9 |
Lyons M. et al. (2012) [36] | Total, 73 | Photofrin® | Hematoporphyrin derivative (HpD) | 2 mg/kg | Cell membrane; mitochondria | 630 | 100 | Mean survival 62.9 weeks |
Levulan | 5-ALA | |||||||
Johansson et al. (2013) [37] | Total, 5 | Levulan | 5-ALA | 20–30 mg/kg | Cell membrane; mitochondria | 630 | 720 | - |
Muragaki et al. (2013) [38] | Newly diagnosed, 13 | Laserphyrin® | Talaporfin sodium | 40 mg/m2 | - | 664 | 27 | Newly diagnosed, 24.8 |
5-ALA, 5-aminolevulinic acid.